NCT06238778: An ongoing trial by Diasome Pharmaceuticlas, Inc.
This trial is ongoing. It must report results 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06238778 |
|---|---|
| Title | A Phase 2b Randomized, Double-blind Trial Comparing HDV-Insulin Lispro Versus Insulin Lispro Alone in Adults With Type 1 Diabetes Receiving Insulin Degludec |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 23, 2024 |
| Completion date | Oct. 31, 2025 |
| Required reporting date | Oct. 31, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 29, 2026 |
| Days late | None |